Prosight Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
GS
Prosight Management's CDNA Position: Q1 2026 in Review
Prosight Management sold out of CareDx (CDNA) in Q1 2026, closing a stake of 250,000 shares — an estimated $4.71M sold.
Prosight Management first reported a position in CDNA in Q4 2024 and held it in 5 quarters. The position peaked at $7.33M in Q3 2025. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Prosight Management reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
- Prosight Management sold 250,000 CareDx shares in Q1 2026, an estimated $4.71M.
- Prosight Management first reported a position in CareDx in Q4 2024 and held it in 5 quarters.
- Prosight Management's CareDx position peaked at $7.33M in Q3 2025.
- 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Prosight Management's 13F filing for Q1 2026, filed 15 May 2026.